483 James G. Kublin MD Apr 2015

483 James G. Kublin MD Apr 2015

Kathryn Krentz FDA$119.00 - Available Now

FDA investigators audited the James G. Kublin MD - Seattle, WA, United States facility and issued inspectional observations (via FDA 483) on 23 Apr 2015.

Product details

  • Category: Biologics
  • Inspection end: 23 Apr 2015
  • Location: Seattle, United States
  • FEI: 3011302754
Add To Cart